p27-deficient mouse exhibiting tissue hypertrophy
Hypercellular nonhuman organisms have functionally inactivated expression of a cyclin inhibitor gene, especially p27. The growth rate of nonhuman organisms are increased such that a desired size is attained more quickly than as compared to nonvariant organisms. Inhibitors of the p27 cyclin dependent kinase inhibitor protein or sequences encoding the protein modulate vertebrate cell cycle progression and increase the proportion of dividing cells to non-dividing cells in a population of treated cells. As the proportion of dividing cells increases, the cell population, e.g., hematopoietic progenitor (stem) cells, is more efficiently used for gene therapy applications. Transgenic animals and plants, and knockout alleles are provided.
1. A transgenic mouse whose genome comprises a homozygous disruption of the endogenous cyclin inhibitor p27 gene locus, wherein said disruption results in the functional inactivation of the p27 gene, and wherein said mouse exhibits tissue hypertrophy relative to a mouse whose genome comprises the functional endogenous cyclin inhibitor p27 gene.
2. The hypertrophic mouse according to claim 1 , wherein the p27 gene is replaced with a replacement gene.
3. The hypertrophic mouse according to claim 2 , wherein the replacement gene comprises a neomycin resistance gene, a Herpes simplex virus thymidine kinase gene, or a gpt gene.
4. The hypertrophic mouse according to claim 1 , wherein the endogenous p27 gene is partially replaced with a corresponding portion of a heterologous p27 gene that is functionally inactivated.
5. The hypertrophic mouse according to claim 1 , wherein all or a portion of the p27 gene is deleted.
6. The hypertrophic mouse according to claim 1 , wherein the p27 gene is functionally inactivated by integration at the p27 gene locus with a targeting construct comprising at least a portion of a sequence substantially homologous to a sequence present in or flanking the p27 gene locus.
7. The hypertrophic mouse according to claim 1 , wherein the p27 gene is functionally inactivated by an insertion comprising a replacement sequence.
8. The hypertrophic mouse according to claim 1 , wherein the p27 gene is functionally inactivated by a site-specific point mutation.